Abstract
Background: Urothelial carcinoma of the bladder is common cancer. Despite advances in treatments and the introduction of immune checkpoint inhibitors in recent years, metastatic disease carries a poor prognosis
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have